Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-E...(9 376 45 46 267 305 ...)

Vegetable

and fruit

seed 168 155 612 569 57 75 267 296

All other

crops seeds

and traits 119 85 325 280 72 44 171 146

TOTAL Seeds

and

Genomics $742 $531 $4,964 $3,978 $359 $248 $3,014 $2,433

($ in millions) Earnings Before Interest & Taxes (EBIT)

Fourth Fourth Fiscal Fiscal

Seeds and Genomics Quarter Quarter Year Year

2007 2006 2007 2006

EBIT (For a reconciliation of

EBIT, see note 2.) $(397) $(228) $905 $794

Unusual Items Affecting EBIT

DPL Acquired In-Process R&D $(186) None $(186) None

Income (Loss) on

discontinued operations $50 $(6) $45 $6

Pre-tax Cumulative Effect of

Change in Accounting

Principle None $(5) None $(5)

The Seeds and Genomics segment consists of the company's global seeds and related traits business, and genetic technology platforms.

Sales for Monsanto's Seeds and Genomics segment were $742 million for the fourth quarter of fiscal year 2007, or 40 percent higher than sales in the same period last year.

During the fourth quarter of fiscal year 2007, the company realized increased revenues from its corn seed and traits business. The key factors for growth included a successful conclusion to the seed and traits season in the United States and strong farmer demand for the company's corn seed products in Argentina and Brazil.

Monsanto realized record segment sales of $5 billion for fiscal year 2007 which were 25 percent higher compared with sales last fiscal year. The key driver for growth in the fiscal ye
'/>"/>